Review
Medicine, General & Internal
Kelsey Goostrey, Susanne Muehlschlegel
Summary: Prognostication in the neuroICU is crucial for surrogate decision makers and patients, but there is considerable variability and lack of guidelines. Shared decision making has been proposed as an opportunity to improve communication and ensure individualized decisions based on patient values and preferences.
BMJ-BRITISH MEDICAL JOURNAL
(2022)
Article
Oncology
D. Bhamidipati, A. Colina, H. Hwang, H. Wang, M. Katz, K. Fournier, V Serpas, J. Thomas, R. Sun, R. A. Wolff, K. Raghav, M. J. Overman
Summary: Metastasectomy may improve overall survival in selected patients with SBA; Fluoropyrimidine plus platinum is a common first-line chemotherapy option; Immune therapy is effective for deficient mismatch repair (dMMR) SBA.
Article
Critical Care Medicine
Shawn P. E. Nishi, Lisa M. Lowenstein, Tito R. Mendoza, Maria A. Lopez, Laura C. Crocker, Karen Sepucha, Jiangong Niu, Robert J. Volk
Summary: Among patients recently assessed for LCS, the quality of decision-making is highly variable, with patients valuing early cancer detection over concerns about harms. Patients were more likely to receive information on the benefits of LCS than on the risks, and one-third experienced some degree of decisional conflict. However, most patients felt they were adequately involved in the screening decision-making process.
Article
Nursing
Ya-Fang Ho, Yu-Chi Chen, I-Chuan Li
Summary: This study explores the change process among chronic kidney disease patients in shared decision-making, identifying three themes: from avoidance to being forced to accept, decision-making process of action, and facilitating factors. After making the necessary psychological adjustments for dialysis treatment, patients experience the process of decision-making action.
Review
Public, Environmental & Occupational Health
Xuejing Li, Dan Yang, Meiqi Meng, Junqiang Zhao, Yiyi Yin, Hefang Wang, Xiaoyan Zhang, Qian Liu, Mengdi Li, Jianping Liu, Yufang Hao
Summary: Shared decision-making (SDM) is in its early stages in mainland China. There is a lack of comprehensive understanding of decisional needs concepts, and limited research on decision support and decisional outcomes. Uniform standards for developing patient decision aids are lacking. Chinese SDM studies primarily focus on physiological needs.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Oncology
Tiuri E. Kroese, Yuko Takahashi, Florian Lordick, Peter S. N. van Rossum, Jelle P. Ruurda, Sjoerd M. Lagarde, Richard van Hillegersberg, Rob H. A. Verhoeven, Hanneke W. M. van Laarhoven
Summary: This population-based cohort study evaluated the treatment and survival outcomes in gastric cancer patients with liver metastases. The study found that liver oligometastatic disease and trastuzumab treatment were associated with better overall survival, while triplet chemotherapy was not significantly different from doublet chemotherapy.
EUROPEAN JOURNAL OF CANCER
(2023)
Article
Cardiac & Cardiovascular Systems
Meghan Reading Turchioe, Sabrina Mangal, Jessica S. Ancker, Jaslynn Gwyn, Paul Varosy, David Slotwiner
Summary: This study aimed to measure decision quality and describe decision-making processes for catheter ablation in patients with atrial fibrillation (AF). The findings showed a disconnect between physician efforts to provide information and boost patient agency in decision-making and patient experiences. A decision aid, preferably an interactive web-based tool, that presents evidence using data, visualizations, videos, and personalized risk assessments in multiple languages may be needed to improve decision quality.
EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
(2023)
Article
Computer Science, Information Systems
Kuang-Ming Kuo, I-Chiu Chang, Chih-Ming Chen, Feng-Jung Yang
Summary: Chronic kidney disease (CKD) has a significant negative impact on patients, and the focus on improving CKD patients' conditions through shared decision-making is increasing. This study explores the antecedents and effects of shared decision-making, as well as the influence of different types of communication methods.
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS
(2022)
Review
Public, Environmental & Occupational Health
Elizabeth C. Thomas, Sarah Bauerle Bass, Laura A. Siminoff
Summary: The contemporary healthcare field operates on an autonomy model of medical decision-making, yet shared decision-making lacks attention to descriptive influences which limits its development. A multi-level approach is proposed to tailor the decision encounter, strategically use relational elements, and modify incentive models to promote the practice of shared decision-making. These modifications are expected to make shared decision-making more inclusive, effective, and acceptable to diverse patients.
SOCIAL SCIENCE & MEDICINE
(2021)
Review
Public, Environmental & Occupational Health
Kang An, Zengxiang Wu, Yu Qiu, Mengjia Pan, Lin Zhang, Zhenmei An, Shuangqing Li
Summary: The implementation of shared decision making (SDM) in sarcopenia management is still in its early stage, but accumulating evidence suggests its importance in elderly care. This study provides an overview of general SDM practices and explores potential advantages and challenges of incorporating them into sarcopenia management. Structured techniques, such as the seek-help-assess-reach-evaluate approach, can effectively integrate SDM into daily practice and improve patient adherence and satisfaction. Further research is needed to address barriers to SDM implementation and explore measurement and outcomes, coordination and cooperation, and digital technology. The study concludes that integrating SDM into clinical practice offers promising opportunities to improve patient care, with patient-centered and partnership approaches positively impacting treatment outcomes.
FRONTIERS IN PUBLIC HEALTH
(2023)
Article
Education, Scientific Disciplines
Matthew Zegarek, Rebecca Brienza, Noel Quinn
Summary: Shared decision making (SDM) is a collaborative process that involves discussing preference-sensitive decisions with patients in an accessible format, allowing them to select an option that aligns with their values and preferences within the context of evidence-based medicine. Although SDM has shown to improve certain quality of care metrics and is included in competencies developed by accreditation bodies, incorporating SDM competencies into clinical teaching can be challenging.
Review
Urology & Nephrology
Mariana Murea, Carl R. Grey, Charmaine E. Lok
Summary: Shared decision-making (SDM) is important in vascular access planning for hemodialysis patients but is not widely practiced. There is a need to shift from a prescriptive approach to a patient-centered care model in this field.
KIDNEY INTERNATIONAL
(2021)
Article
Public, Environmental & Occupational Health
Glyn Elwyn
Summary: Cooperation is a fundamental characteristic of human society, and respecting individual agency, providing information, and collaborating are ethical imperatives, particularly in healthcare decision-making. Shared decision making involves cognitive, emotional, and relational work with the goal of restoring patient autonomy.
PATIENT EDUCATION AND COUNSELING
(2021)
Review
Gastroenterology & Hepatology
Andras Bibok, Dae Won Kim, Mokenge Malafa, Bela Kis
Summary: Pancreatic cancer presents challenges with limited treatment options and poor prognosis. Chemotherapy is the standard first-line treatment for locally advanced pancreatic cancer, while it is also the primary option for patients with metastatic pancreatic cancer. New ablative techniques and liver-directed therapies are emerging as potential treatment options for these patients, showing promise in improving overall survival.
WORLD JOURNAL OF GASTROENTEROLOGY
(2021)
Article
Health Care Sciences & Services
Ellen M. Driever, Anne M. Stiggelbout, Paul L. P. Brand
Summary: The level of patient involvement in medical specialist consultations is influenced by the type of decision being made and the duration of the consultation. Patients are most involved in treatment decisions and least involved in other types of decisions. It is recommended that physicians assist patients in participating in different types of decisions and allow sufficient time for shared decision-making.
JOURNAL OF GENERAL INTERNAL MEDICINE
(2022)
Article
Urology & Nephrology
Sarah P. Psutka, Mark Heidenreich, Stephen A. Boorjian, George C. Bailey, John C. Cheville, Suzanne B. Stewart-Merrill, Christine M. Lohse, Thomas D. Atwell, Brian A. Costello, Bradley C. Leibovich, R. Houston Thompson
Article
Oncology
Roman Gulati, Todd M. Morgan, Teresa A'mar, Sarah P. Psutka, Jeffrey J. Tosoian, Ruth Etzioni
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2020)
Article
Oncology
Adam J. Gadzinski, Sarah P. Psutka
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
(2020)
Editorial Material
Oncology
Sarah P. Psutka
Article
Oncology
Leonidas N. Diamantopoulos, Sarah K. Holt, Ali R. Khaki, Rishi R. Sekar, Adam Gadzinski, Yaw A. Nyame, Funda Vakar-Lopez, Maria S. Tretiakova, Sarah P. Psutka, John L. Gore, Daniel W. Lin, George R. Schade, Andrew C. Hsieh, John K. Lee, Todd Yezefski, Michael T. Schweizer, Heather H. Cheng, Evan Y. Yu, Lawrence D. True, Robert B. Montgomery, Petros Grivas, Jonathan L. Wright
Summary: The study found that the pathologic response to neoadjuvant chemotherapy was similar between micropapillary bladder carcinoma and conventional urothelial carcinoma. Although micropapillary bladder carcinoma presents with more aggressive features, it is not associated with worse outcomes compared to conventional urothelial carcinoma. Further research is needed to better understand the biological mechanisms behind the aggressive features of micropapillary bladder carcinoma and the role of neoadjuvant chemotherapy in this histological variant.
CLINICAL GENITOURINARY CANCER
(2021)
Article
Oncology
Michelle I. Higgins, Dylan J. Martini, Dattatraya H. Patil, Reza Nabavizadeh, Sean Steele, Milton Williams, Shreyas S. Joshi, Vikram M. Narayan, Aarti Sekhar, Sarah P. Psutka, Kenneth Ogan, Mehmet Asim Bilen, Viraj A. Master
Summary: The study revealed that low muscle mass and markers of inflammation were associated with an increased risk of recurrence and death in patients with localized RCC after surgery.
Editorial Material
Urology & Nephrology
Pauline Filippou, Brian Shuch, Sarah P. Psutka
Review
Urology & Nephrology
Michelle Higgins, J. Peter Marquardt, Viraj A. Master, Florian J. Fintelmann, Sarah P. Psutka
Summary: Body composition analysis (BCA) uses objective anthropometric data to inform urologic prognostication and treatment decisions. Machine learning (ML) has the potential to automate and scale accurate BCA, relying on convolutional neural networks to analyze images. This review discusses the use of ML in BCA and its translation into clinical practice.
EUROPEAN UROLOGY FOCUS
(2021)
Letter
Urology & Nephrology
Logan G. Briggs, Sara Parke, Paul A. Bain, Sarah P. Psutka
Editorial Material
Urology & Nephrology
Sarah P. Psutka, Todd Morgan, Maarten Albersen, Jean-Nicolas Cornu, Giacomo Novara, Elizabeth Plimack, Piet Ost, James W. F. Catto
Review
Urology & Nephrology
Logan G. Briggs, Chanan Reitblat, Paul A. Bain, Sara Parke, Ny-Ying Lam, Jonathan Wright, James W. F. Catto, Robert J. Copeland, Sarah P. Psutka
Summary: This study systematically assessed the therapeutic validity and efficacy of prehabilitation exercise programs before urologic cancer surgery. While these programs improve cardiorespiratory fitness and quality of life, their impact on surgical outcomes remains inconclusive.
Article
Oncology
Amir Ishaq Khan, Sarah P. Psutka, Dattatraya H. Patil, Gordon Hong, Milton A. Williams, Mehmet A. Bilen, Aarti Sekhar, Haydn T. Kissick, Vikram M. Narayan, Shreyas S. Joshi, Kenneth Ogan, Viraj A. Master
Summary: Sarcopenia and high systemic inflammation are independently associated with poor OS after CN, providing potential use in preoperative risk stratification.
Article
Oncology
Yuanquan Yang, Sarah P. Psutka, Anish B. Parikh, Mingjia Li, Katharine Collier, Abdul Miah, Sherry Mori, Megan Hinkley, Scott S. Tykodi, Evan Hall, John A. Thompson, Ming Yin
Summary: The combination of immune checkpoint inhibitor/tyrosine kinase inhibitor (ICI/TKI) is a new standard of care for the initial treatment of metastatic renal cell carcinoma (mRCC), but its efficacy and toxicity beyond the first-line setting are still uncertain.
Article
Medicine, Research & Experimental
Sarah P. Psutka, Susan Veleber, Jonathan Siman, Samia Jannat, Sarah Holt, Jonathan L. Wright, Heather Greenlee
Summary: This study describes a pilot randomized controlled trial testing the use of acupuncture to reduce serious adverse events and treatment interruptions in patients with bladder cancer. A total of 45 patients will be recruited and randomized into treatment and control groups for pre-procedure acupuncture in a Urology Clinic to assess feasibility and efficacy. Feasibility assessments include recruitment, retention, protocol adherence, adverse events monitoring, and impact on clinic workflow, with efficacy measures focusing on various patient-reported outcomes and healthcare utilization. Trial results will guide the development of a larger multi-center trial for further testing of the protocol.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS
(2022)
